Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00096317 · ClinicalTrials.gov registry record · Phase 1
Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 29
- Enrollment target
NCT00096317 is a Phase 1 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 29 participants.
The verdict
NCT00096317, a Phase 1 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 29 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy, such as ixabepilone and ketoconazole, work in different ways to stop tumor cells from dividing so they stop growing or die. Giving ixabepilone with ketoconazole may kill more tumor cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of giving ixabepilone together with ketoconazole and to see how well they work in treating patients with advanced solid tumors.
Interventions
- DRUG ixabepilone
- DRUG ketoconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2003-03 |
| Est. Completion | 2005-12-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00096317
The ClinicalTrials.gov registry entry for NCT00096317 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ixabepilone is the first listed.
NCT00096317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00096317 about?
NCT00096317 is a clinical study titled "Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors". RATIONALE: Drugs used in chemotherapy, such as ixabepilone and ketoconazole, work in different ways to stop tumor cells from dividing so they stop growing or die. Giving ixabepilone with ketoconazole may kill more tumor cells. PURPOSE: This phase I/II trial is studying the side effects and best dos...
What is the current status of trial NCT00096317?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2003-03. Estimated completion is 2005-12-05.
What interventions are being tested in trial NCT00096317?
The interventions under investigation include: ixabepilone (DRUG), ketoconazole (DRUG).
Who is sponsoring clinical trial NCT00096317?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.